El.En. S.p.A. · MIL:ELN

El.En — Q3 2015 Earnings Presentation

32 slides from El.En's earnings presentation, Dec 1, 2015

  1. Slide 1: Company Presentation Q3 2015 Financial Results

    COMPANY PRESENTATION Q3 2015 FINANCIAL RESULTS INTERMONTE Dec. 1st , 2015

  2. Slide 2: Disclaimer

    Disclaimer Certain statements in this slide show, including those addressing the Company’s beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-looking statements involve known or unknown risks, including general economic

  3. Slide 3: Summary

    Summary 1. LASERS AND LASER APPLICATIONS 2. THE GLOBAL LASER MARKET 3. EL.EN. GROUP 4. Q3 - 2015 FINANCIAL RESULTS 5. 2015 GUIDANCE 6. EL.EN. STOCK, MULTIPLES & COMPARABLES

  4. Slide 4: Lasers and Laser Applications

    Lasers and Laser Applications

  5. Slide 5: LASER

    LASER Light Amplification by Stimulated Emission of Radiation MEDICAL LASER Systems INDUSTRIAL LASER Systems

  6. Slide 6: Medical and Aest. Applications

    Medical and Aest. Applications

  7. Slide 7: Industrial lasers applications

    Industrial lasers applications

  8. Slide 8: Hot Products

    Hot Products Monna Lisa Touch Mediostar Cyber TM 200

  9. Slide 9: New Products

    New Products Multipulse HoPLUS Discovery Pico Motus AX

  10. Slide 10: The Global Laser Market

    ° ——ELEN. Group The Global Laser Market ai

  11. Slide 11: The MEDICAL Laser Market

    The MEDICAL Laser Market Global market for medical lasers by end use, through 2019 ($ millions) Market Segment 2013 2014 2019 CAGR% 2014-2019 Surgical 758 813 1.219 8,4% Cosmetic 895 1.024 2.097 15,4% Dental 209 244 623 20,7% Veterinary 99 115 247 16,5% Total 1.961 2.195 4.185 13,8% Global market fo

  12. Slide 12: The INDUSTRIAL Laser Market

    The INDUSTRIAL Laser Market Global market and forecast for high power laser systems by application (by value) By Value Global Market (EUR Million) CAGR (%) 2013 2016 2020 2013-2016 2016-2020 Cutting 2.408 3.014 3.965 7,8 7,1 Welding and Brazing 1.249 1.605 2.231 8,7 8,6 Surface treatment and Other 5

  13. Slide 13: El.En. Group

    —— EL En. Group El.En. Group

  14. Slide 14: Group Overview

    Group Overview High –Tech laser photonics Group Develops, manufactures and distributes laser sources and laser systems for medical and industrial applications Know-how based on 30 years stratification of multidisciplinary experience Q3 2015: Consolidated Revenues of €156 mln, up 25% YoY 985 employee

  15. Slide 15: El.En. Group

    El.En. Group C.&.

  16. Slide 16: Strategic Strengths

    Strategic Strengths Multidisciplinary and multifacility R&D activity: sources, systems, applications Industrial Combine High tech laser source development with flexible production facilities in high growth areas Medical Technological and clinical innovation improving performance and broadening the a

  17. Slide 17: Consolidated Revenues and EBIT

    Consolidated Revenues and EBIT 225 25 SALES EBIT 200 20 175 150 15 125 10 100 75 5 50 0 25 0 (5) 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015E

  18. Slide 18: R&D Activity

    R&D Activity Clinical trials and validations of new therapeutic laser treatments and research on new applications of laser- tissue interaction Broadening Mona Lisa Touch Clinical studies Central role of PHOTOBIOLAB Clinical studies on cutaneous ulcers New Pico second laser platform New approach to l

  19. Slide 19: Q3 - 2015 Financial Results

    Q3 - 2015 Financial Results ai

  20. Slide 20: Consolidated P&L

    Consolidated P&L Euro/000 30/09/14 30/09/15 Var.% Revenues 124.616 100,0% 156.006 100,0% 25,2% Gross margin 57.274 46,0% 70.236 45,0% 22,6% EBITDA 11.964 9,6% 19.310 12,4% 61,4% EBIT (*) 10.532 8,5% 16.193 10,4% 53,7% Pretax Income (**) 18.744 15,0% 17.191 11,0% -8,3% (*) 2014 Non recurring: +1,5 ml

  21. Slide 21: Net financial position

    Net financial position Euro '000 31/12/14 30/09/15 Var. Net financial position : 47.116 23.075 24.041 Decrease due to: - 10,5 mln: temporary investments in non current assets - 5,3 mln: dividends paid - 5,0 mln: capex - 3,0 mln: cash flow from operations

  22. Slide 22: Medical Lasers Business

    Medical Lasers Business 60 +1% +25% YoY 50 40 Mln 30 +119% +45% 20 -6% 10 - Aesthetic Surgical Physiotherapy Service 9/14 9/15

  23. Slide 23: Medical Lasers: Breakdown by Area

    Medical Lasers: Breakdown by Area 30 +124% +33% 25 -3% +2% 20 +11% Mln 15 10 5 -18% 0 Italy Europe North Americas F/M East Japan America 9/14 9/15

  24. Slide 24: Industrial Lasers Business

    Industrial Lasers Business 35 +24% +26% YoY 30 25 20 Mln 15 +16% 10 +11% 5 +623% - Cutting Marking Laser sources Service 9/14 9/15

  25. Slide 25: Industrial Lasers: Breakdown by Area

    Industrial Lasers: Breakdown by Area 30 +23% 25 20 Mln15 +24% 10 +57% -6% 5 0 Italy Europe Americas Far East 9/14 9/15

  26. Slide 26: 2015 Guidance

    2015 Guidance ai

  27. Slide 27: 2015 Guidance

    2015 Guidance Sales: >210 mln +17% EBIT: >20 mln

  28. Slide 28: El.En. Stock, Multiples & Comparables

    El.En. Stock, Multiples & Comparables

  29. Slide 29: El.En. Stock

    El.En. Stock 6a. 45 30 25 20 15 10 | i i | = | | | | a | = i i ! | ae | . 2001 2002 2003 2004 2005— 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 www.elengroup.com

  30. Slide 30: El.En. Multiples

    El.En. Multiples Stockholder's Equity per share * 34 Price / Book Value Adj. 1,29 EV /EBIT (85% EBIT) 7,47 EV / Sales (85% Sales) 0,78 El.En. Market Cap. 209,9 @ € 43,50 Net financial position 23,1 @ 30/09/15 Financial investments m/l term 10,6 @ 30/09/15 Market value of 1,0 mm Cynosure shares 39,1

  31. Slide 31: El.En. Comparables

    El.En. Comparables Price Revenue Var.% EBIT EBIT % MK.Cap. EV EV/Sales EV/EBIT P/Book Sept 30, 2015 Revenue (*) (*) Value Medical/Aesthetic Syneron $7,64 $198.959 10% $(8.476) -4% $269.210 $189.688 0,72 n.a. 1,26 Zeltiq $30,75 $177.191 43% $1.895 1% $1.220.000 $1.173.440 4,97 464,42 15,42 Cutera $14

  32. Slide 32: El.En. SPA Investor Relations contacts

    El.En. SPA Enrico ROMAGNOLI Investor Relations Manager tel. +39 055-8826807 E-mail: finance@elen.it POLYTEMS HIR SRL Bianca FERSINI MASTELLONI Financial Communication Tel. +39 06-6797849 / +39 06-69923324 E-mail: b.fersini@polytemshir.it POLYTEMS HIR SRL Silvia MARONGIU Press office Tel. +39 06-6797

El.En. — Q3 2015 Earnings Presentation on 6ix